Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Risedronate Therapy in the Treatment of Low Bone Mineral Density in Crohn's Disease

This study has been completed.
Sponsor:
Information provided by:
University of Alberta
ClinicalTrials.gov Identifier:
NCT01215890
First received: October 5, 2010
Last updated: NA
Last verified: October 2010
History: No changes posted
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: No date given